Online Treatment Tool for Patients: Key Information You Need to Know To Inform Your Melanoma Treatment

Download this PDF consultation checklist with useful questions for your oncologist about your melanoma treatment. You can then enter the specific information about your cancer into our interactive treatment tool by answering a series of multiple choice questions to get treatment options chosen by 5 melanoma experts.
Format: Adobe Acrobat (.pdf)
File Size: 129 KB
Released: May 3, 2019

Acknowledgements

Provided by Postgraduate Institute for Medicine
PIM Logo

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Grace Logo
This activity is supported by educational grants from
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation

Related Content

Expert faculty share patient case examples from clinical practice that highlight the importance of biomarker testing for NSCLC, from Clinical Care Options (CCO)

Charles W. Flexner, MD Released: September 23, 2022

CheckMate 915: association of ctDNA and other translational factors at baseline with RFS in patients with stage IIIB-D/IV melanoma receiving adjuvant immunotherapy, presented at ESMO 2022 and reported by Clinical Care Options (CCO)

Released: September 23, 2022

Phase II SWOG S1801 study: neoadjuvant vs adjuvant treatment with pembrolizumab in patients with resectable stage III-IV melanoma, presented at ESMO 2022 and reported by Clinical Care Options (CCO)

Released: September 23, 2022

Enter the characteristics of your patient with CLL into an online tool from Clinical Care Options (CCO) to see treatment recommendations from 5 experts

Farrukh T. Awan, MD Jennifer R. Brown, MD, PhD Nicole Lamanna, MD Anthony Mato, MD, MSCE Jeff Sharman, MD Released: September 22, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings